tiprankstipranks
Trending News
More News >
Promore Pharma AB (DE:8T00)
:8T00
Germany Market

Promore Pharma AB (8T00) Income Statement

Compare
0 Followers

Promore Pharma AB Income Statement

Last quarter (Q2 2022), Promore Pharma AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Promore Pharma AB's net income was $-6.14M. See Promore Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ -14.89M$ -18.19M$ -16.37M$ -22.01M$ -10.31M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 0.00$ 609.00K$ 1.22M$ 1.22M$ 1.22M
EBITDA
$ -26.60M$ -28.49M$ -27.55M$ -31.21M$ -6.79M
Operating Income
$ -26.69M$ -29.09M$ -29.07M$ -32.68M$ -9.58M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -26.77M$ -29.41M$ -28.86M$ -32.48M$ -8.43M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Promore Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis